1. Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship.
   Romana T Netea-Maier et al, 2018, Cancer Lett CrossRef
2. Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis
   Paola Perrotta et al, 2018, Vascular Pharmacology CrossRef
3. Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation
   Rossana Pesi et al, 2018, IJMS CrossRef
4. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway
   Ting Ma et al, 2016, Sci Rep CrossRef
5. Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond?
   Lynn Jeanette Savic et al, 2016, Hepatic Oncology CrossRef
6. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
   A.P. Alves et al, 2018, CCDT CrossRef
7. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
   Ali F Abdel-Wahab et al, 2019, Pharmacol Res CrossRef
8. PI3K/Akt/FoxO pathway mediates glycolytic metabolism in HepG2 cells exposed to triclosan (TCS)
   Jing An et al, 2020, Environment International CrossRef
9. null
   Tomas Koltai et al, 2020 CrossRef
10. Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma
    Jiang-Tao Zhong et al, 2017, Oncotarget CrossRef
11. Adipose tissue dysfunction and its effects on tumor metabolism
    Jonathan Diedrich et al, 2015 CrossRef
12. Moderate endurance training reduced hepatic tumourigenesis associated with lower lactate overload compared to high‐intensity interval training
    Lu Cao et al, 2021, Clin Exp Pharmacol Physiol CrossRef
13. null
    Tomas Koltai et al, 2021 CrossRef
14. Ethanol extracts of Balanophora laxiflora Hemsl inhibit hepatocellular carcinoma with the involvement of HKII-mediated glycolysis
    Dan Liu et al, 2021, Journal of Functional Foods CrossRef
15. Warburg and pasteur phenotypes modulate cancer behavior and therapy
    Caner Karaca et al, 2022 CrossRef
16. MARK2 potentiate aerobic glycolysis‐mediated cell growth in breast cancer through regulating mTOR/HIF‐1α and p53 pathways
    Lavanya Ponnusamy et al, 2022, J of Cellular Biochemistry CrossRef
17. Low vitamin D and high cholesterol facilitate oral carcinogenesis in 4NQO‐induced rat models via regulating glycolysis
    Rasim Gumus et al, 2022, Oral Diseases CrossRef
18. Novel mutation in hexokinase 2 confers resistance to 2-deoxyglucose by altering protein dynamics
    Erich Hellemann et al, 2022, PLoS Comput Biol CrossRef
19. 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
    Zoufang Huang et al, 2022, Front. Pharmacol. CrossRef
20. The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
    G. S. Gupta, 2022, Inflammation CrossRef
21. Glycolytic stress deteriorates 229E virulence to improve host defense response
    Neha Kaushik et al, 2023, Microbes and Infection CrossRef
22. FDP-Na-induced enhancement of glycolysis impacts larval growth and development and chitin biosynthesis in fall webworm, Hyphantria cunea (Lepidoptera: Arctiidae)
    Shengyu Zhang et al, 2023, Pesticide Biochemistry and Physiology CrossRef
23. Mitochondrial dynamics and metabolic regulation control T cell fate in the thymus
    Rima Elhage et al, 2024, Front. Immunol. CrossRef
24. Autophagy inhibition potentiates energy restriction‐induced cell death in hepatocellular carcinoma cells
    Sara M. Elgendy et al, 2024, IUBMB Life CrossRef
25. Breast cancer therapy: from the perspective of glucose metabolism and glycosylation
    Jiaqi Zhao et al, 2024, Mol Biol Rep CrossRef
26. Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferation
    Ying Meng et al, 2024, Nat Metab CrossRef